Milestone Pharmaceuticals (NASDAQ:MIST) reported its Q3 earnings results on Monday, November 13, 2023 at 06:57 AM.
Here’s what investors need to know about the announcement.
Earnings
Milestone Pharmaceuticals beat estimated earnings by 7.89%, reporting an EPS of $-0.35 versus an estimate of $-0.38.
Revenue was down $1.50 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02 which was followed by a 3.94% drop in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Milestone Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
